Aptose Biosciences Inc. (NASDAQ: APTO)
$0.71
+0.0066 ( +0.94% ) 20.0K
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.
Market Data
Open
$0.71
Previous close
$0.70
Volume
20.0K
Market cap
$12.41M
Day range
$0.69 - $0.73
52 week range
$0.67 - $5.10
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Feb 07, 2024 |
8-k | 8K-related | 16 | Jan 31, 2024 |
8-k | 8K-related | 25 | Jan 30, 2024 |
8-k | 8K-related | 14 | Jan 26, 2024 |
8-k | 8K-related | 14 | Dec 11, 2023 |
8-k | 8K-related | 14 | Nov 30, 2023 |
8-k | 8K-related | 14 | Nov 09, 2023 |
10-q | Quarterly Reports | 69 | Nov 09, 2023 |
8-k | 8K-related | 14 | Nov 02, 2023 |
8-k | 8K-related | 14 | Oct 30, 2023 |